This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Dec 11;376(9757):1968-70.

doi: 10.1016/S0140-6736(10)62194-0. Epub 2010 Dec 3.

Mitoxantrone in first-relapse paediatric ALL: the ALL R3 trial

Martin Schrappe¹

Affiliations

PMID: 21131040
DOI: 10.1016/S0140-6736(10)62194-0

Comment

Mitoxantrone in first-relapse paediatric ALL: the ALL R3 trial

Martin Schrappe. Lancet. 2010.

. 2010 Dec 11;376(9757):1968-70.

doi: 10.1016/S0140-6736(10)62194-0. Epub 2010 Dec 3.

Author

Martin Schrappe¹

Affiliation

¹ Centre of Paediatrics, University Medical Centre Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany. m.schrappe@pediatrics.uni-kiel.de

PMID: 21131040
DOI: 10.1016/S0140-6736(10)62194-0

No abstract available

PubMed Disclaimer

Comment on

Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial.
Parker C, Waters R, Leighton C, Hancock J, Sutton R, Moorman AV, Ancliff P, Morgan M, Masurekar A, Goulden N, Green N, Révész T, Darbyshire P, Love S, Saha V. Parker C, et al. Lancet. 2010 Dec 11;376(9757):2009-17. doi: 10.1016/S0140-6736(10)62002-8. Epub 2010 Dec 3. Lancet. 2010. PMID: 21131038 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science